This company has shut down. Eyebiotech is no longer operating — its last tracked round was a Series A in 2023.
Explore the Startup GraveyardEyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.
Eyebiotech has raised $65.0M in total funding. The most recent round was Series A. The last funding was announced in November 2023.
Eyebiotech's investors include Jeito Capital, SV Health Investors, Samsara BioCapital, Vertex Ventures HC, Omega Funds.
Eyebiotech is headquartered in New York, United States.
Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.
Eyebiotech is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eyebiotech — Funding & Investors." VCBacked, November 14, 2023, https://www.vcbacked.co/company/eyebiotech. Accessed July 20, 2026.
VCBacked. (2023). Eyebiotech — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/eyebiotech
{{cite web |title=Eyebiotech — Funding & Investors |url=https://www.vcbacked.co/company/eyebiotech |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated